VERA Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own VERA shares is 263, representing 94.85% of the company's common stock.

SOFINNOVA INVESTMENTS, INC., in the last quarter, reduced its stake in VERA by -19.42% restricting it's holding to 2.79 million shares of worth nearly $120.48M. PROFUND ADVISORS LLC also lessened -1.52% of the VERA shares from its portfolio, reducing its holding to 27.35 thousand shares of worth $1.18B. ORBIMED ADVISORS LLC also shunned VERA shares holding by -55.48% last quarter which brought its holding to 675.87 thousand shares worth $29.14M.

As per its latest 13F filing, STATE OF WISCONSIN INVESTMENT BOARD increased its stake in VERA by 48.25% in the last quarter. The institutional holder raised its holding to 27.74 thousand shares having worth more than $1.20M. METLIFE INVESTMENT MANAGEMENT, LLC also added 13.36% more shares of VERA to its portfolio, raising its holding to 20.65 thousand shares of worth $890.56K. QUBE RESEARCH & TECHNOLOGIES LTD also increased its VERA shares holding by 100% which brought its holding to 20.36 thousand shares worth $877.75K.

The insider with the most stakes in VERA is COMMODORE CAPITAL LP , 10 percent owner at the company. Additionally, VERA stock is highly held by 10 percent owner Sofinnova Venture Partners X, L.P. and Carlyle Genesis UK LLC among others.

Company executives, directors, and other insiders own 6.89% percent of Vera Therapeutics, Inc.'s stock. Within the last six months, there have been 14 transaction(s) in which VERA insiders have sold stock, totaling 76.54K shares. Insiders that have sold shares include FORDYCE MARSHALL, SEIDENBERG BETH C, and YOUNG JOSEPH R.

There have been 0 transaction(s) during the past 6-months in which Vera Therapeutics, Inc. insiders have bought stock, totalling 0 shares

Around 2.88M Vera Therapeutics, Inc. shares are held by insiders, which represents about 6.89% of VERA stock.

VERA 10 percent owner, COMMODORE CAPITAL LP holds the largest portfolio of the company's shares. VERA shares owned by COMMODORE total nearly 4.4 million.

SOFINNOVA INVESTMENTS, INC. is the largest institutional owner in VERA which holds 2.79 million shares worth $120.48M or 6.54% of the total VERA shares outstanding followed by STATE OF WISCONSIN INVESTMENT BOARD with ownership of 27.74 thousand shares representing 0.07% of the VERA ownership. PROFUND ADVISORS LLC is the third largest stakeholder with 27.35 thousand shares or 0.06% of the ownership worth more than $1.18B.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the VERA is concerned, it is a stock which is optionable.

Number of VERA shares short is 7.15M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 63.32M shares of VERA are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, VERA has 51.51M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for VERA is 12.48.